Core Alternative Capital Incyte Corp Transaction History
Core Alternative Capital
- $484 Million
- Q2 2024
A detailed history of Core Alternative Capital transactions in Incyte Corp stock. As of the latest transaction made, Core Alternative Capital holds 21 shares of INCY stock, worth $1,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$1,699
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INCY
# of Institutions
624Shares Held
198MCall Options Held
766KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.49 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.73 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.65 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.24 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$878 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $18B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...